[O1] Oral Session 1　Gastrointestinal Cancer 1（Upper GI Tract）
【E】

[O1-4] A randomized phase II trial of neoadjuvant S-1/CDDP +/- trastuzumab in HER2-positive advanced gastric cancer: JCOG1301C

^○Nozomu Machida¹, Masanori Tokunaga², Junki Mizusawa³, Hiroshi Yabusaki⁴, Hirofumi Yasui⁵, Motohiro Hirao⁶, Masaya Watanabe⁷, Takushi Yasuda⁸, Takahiro Kinoshita⁹, Hiroshi Imamura¹⁰, Jun Hihara¹¹, Tomoko Kataoka³, Narikazu Boku¹², Takaki Yoshikawa¹³, Takeshi Sano¹⁴, Mitsuru Sasako¹⁵, Masanori Terashima¹⁶ (1.Department of Gastroenterology, Kanagawa Cancer Center, 2.Tokyo Medical and Dental University, Gastrointestinal Surgery, 3.Japan Clinical Oncology Group Data Center/Operations Office, 4.Niigata Cancer Center Hospital, Division of Surgery, 5.Shizuoka Cancer Center, Division of Gastrointestinal Oncology, 6.National Hospital Organization Osaka National Hospital, Department of Surgery, 7.Shizuoka General Hospital, Department of Gastroenterological Surgery, 8.Kindai University Faculty of Medicine, Department of Surgery, 9.National Cancer Center Hospital East, Department of Gastric Surgery, 10.Toyonaka Municipal Hospital, Department of Surgery, 11.Hiroshima City Asa Citizens Hospital, Department of Surgery, 12.IMS Hospital, Institute of Medical Science, University of Tokyo, Department of Medical Oncology and General Medicine, 13.National Cancer Center Hospital, Department of Gastric Surgery, 14.The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Department of Gastroenterological Surgery, 15.Yodogawa Christian Hospital, Department of Surgery, 16.Shizuoka Cancer Center, Division of Gastric Surgery)